Lonza Group AG (OTCMKTS:LZAGY – Get Free Report) saw a significant drop in short interest in the month of November. As of November 30th, there was short interest totalling 200 shares, a drop of 98.9% from the November 15th total of 18,600 shares. Based on an average daily volume of 286,800 shares, the short-interest ratio is presently 0.0 days.
Lonza Group Stock Up 3.6 %
Shares of Lonza Group stock traded up $2.11 on Friday, reaching $61.09. 26,841 shares of the company traded hands, compared to its average volume of 89,897. The company has a 50 day moving average of $61.06 and a 200 day moving average of $60.52. Lonza Group has a 52 week low of $37.03 and a 52 week high of $67.00.
Wall Street Analysts Forecast Growth
Several research firms have commented on LZAGY. Redburn Atlantic raised shares of Lonza Group to a “strong-buy” rating in a report on Wednesday, November 27th. The Goldman Sachs Group upgraded Lonza Group to a “strong-buy” rating in a research report on Wednesday, October 9th.
About Lonza Group
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
Read More
- Five stocks we like better than Lonza Group
- How to Buy Cheap Stocks Step by Step
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Airline Stocks – Top Airline Stocks to Buy Now
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Consumer Staples Stocks, Explained
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.